Your browser doesn't support javascript.
loading
Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing.
Mee, Edward T; Preston, Mark D; Minor, Philip D; Schepelmann, Silke.
Afiliação
  • Mee ET; Division of Virology, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire EN6 3QG, United Kingdom. Electronic address: edward.mee@nibsc.org.
  • Preston MD; Division of Technology, Development and Infrastructure, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire EN6 3QG, United Kingdom.
  • Minor PD; Division of Virology, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire EN6 3QG, United Kingdom.
  • Schepelmann S; Division of Virology, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire EN6 3QG, United Kingdom.
Vaccine ; 34(17): 2035-43, 2016 Apr 12.
Article em En | MEDLINE | ID: mdl-26709640
ABSTRACT

BACKGROUND:

Unbiased deep sequencing offers the potential for improved adventitious virus screening in vaccines and biotherapeutics. Successful implementation of such assays will require appropriate control materials to confirm assay performance and sensitivity.

METHODS:

A common reference material containing 25 target viruses was produced and 16 laboratories were invited to process it using their preferred adventitious virus detection assay.

RESULTS:

Fifteen laboratories returned results, obtained using a wide range of wet-lab and informatics methods. Six of 25 target viruses were detected by all laboratories, with the remaining viruses detected by 4-14 laboratories. Six non-target viruses were detected by three or more laboratories.

CONCLUSION:

The study demonstrated that a wide range of methods are currently used for adventitious virus detection screening in biological products by deep sequencing and that they can yield significantly different results. This underscores the need for common reference materials to ensure satisfactory assay performance and enable comparisons between laboratories.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus / Produtos Biológicos / Vacinas / Contaminação de Medicamentos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus / Produtos Biológicos / Vacinas / Contaminação de Medicamentos Idioma: En Ano de publicação: 2016 Tipo de documento: Article